Andrew Aschenbrenner

Keyphrases

1. Additive Effect 10%
2. Adults at Risk 9%
3. Alzheimer's Disease 100%
4. Alzheimer's Disease Biomarkers 13%
5. Alzheimer's Disease Pathology 25%
6. Amyloid Positron Emission Tomography 10%
7. Attentional Control 30%
8. Autosomal Dominant Alzheimer's Disease 27%
9. Cerebrospinal Fluid 38%
10. Cerebrospinal Fluid Biomarkers 21%
11. Clinical Dementia Rating 11%
12. Clinical Trials 17%
13. Cognitive Assessment 17%
14. Cognitive Change 13%
15. Cognitive Composite 10%
16. Cognitive Decline 26%
17. Cognitive Impairment 11%
18. Cognitive Measures 11%
19. Cognitively Normal 16%
20. Congruency Sequence Effect 14%
21. Conscientiousness 12%
22. Dementia 14%
23. Diffusion Model Analysis 9%
24. Dominantly Inherited Alzheimer Network 25%
25. Dominantly Inherited Alzheimer's Disease 30%
26. Down Syndrome 9%
27. Driving Behavior 9%
28. Dynamic Adjustment 15%
29. Early Alzheimer's Disease 14%
30. Episodic Memory 22%
31. Gantenerumab 15%
32. Healthy Adults 12%
33. Healthy Aging 28%
34. Hippocampal Volume 13%
35. Imaging Biomarkers 11%
36. Lexical Decision Task 14%
37. Longitudinal Change 20%
38. Mild Alzheimer's Disease 11%
39. Mutation Carriers 13%
40. Neurofilament Light (NF-L) 12%
41. Older Adults 63%
42. Processing Speed 15%
43. Solanezumab 15%
44. Sporadic Alzheimer's Disease 51%
45. Stimulus Quality 9%
46. Symptom Onset 12%
47. Tau PET 15%
48. Trial History 9%
49. Word Frequency 11%
50. Working Memory 12%